Navigation Links
Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China
Date:5/18/2009

BRUSSELS, May 18 /PRNewswire/ -- Solvay Pharmaceuticals announces it has signed an agreement with HUYA Bioscience International, a company specialized in enabling and accelerating global codevelopment of novel biopharmaceutical product opportunities originating in China.

Through this agreement, Solvay Pharmaceuticals will gain access to HUYA's comprehensive Chinese molecule portfolio, focusing specifically on compounds in the cardiovascular area. As some of these molecules are already in advanced stages of development in China, the partnership will help Solvay Pharmaceuticals speed up its early discovery activities as well as increase the company's chances for successfully developing innovative new therapies as safety or efficacy information is already available for some of these molecules.

The pace and quality of China's innovation in the life sciences have led to a significant increase in new product opportunities. Through key collaborations with China's leading academic and commercial organizations, HUYA has gained access to these opportunities to enable and accelerate their worldwide development and commercialization. HUYA has thereby built a most comprehensive Chinese compound portfolio, including a significant number of product candidates targeting cardiovascular diseases to which Solvay Pharmaceuticals will have access under this strategic partnership.

"We look forward to working with HUYA and its highly qualified Chinese partners to identify innovative new molecules and develop them into break-through new therapies for patients and physicians around the globe," said Werner Cautreels, PhD, CEO of Solvay Pharmaceuticals. "We believe that through this partnership, we will be able to speed up our R&D activities by gaining access to compounds that could be introduced in more advanced stages of early development."

According to Mireille Gingras, PhD, President a
'/>"/>

SOURCE Solvay Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
2. 40 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM)
3. Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN...tionsbytheU.S.BankruptcyCourtfortheDistrictofDelaw...untarypetitionfor,reliefunderChapter11oftheUnitedS... TheordersissuedbytheBankruptcyCourtallowthecompan...proceedings.Inparticular,the,companyreceivedinteri...
(Date:11/24/2009)...bleEnergyCorp.announcedtodaythatthecompanyandtheOd...arded$2millionbyWashingtonState,sCommunityEconomic...hiptoconstructthestate,sfirstspecialtybiochemicalb...twillsignificantlyspeedthedevelopmentofourbiorefin...eMarbleEnergyCEOKellyOgilvie."WearegratefultotheGo...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...Customers with Partners Validated to Process and A... , Ottawa, ON (PRWEB) Nov...r of products for biological sample collection, st...ew global partner program. The program offers sign...munity and is designed to help partners scale and ...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... April 8 Amsterdam,Molecular Therapeutics (Eurone...apy, is, as of today, part of the newly created Ne... that NYSE Euronext has selected our company,for t...ndex will increase,the visibility of listed biotec...erformance of our sector.", The index is publishe...
...Milestone Payment, CARLSBAD, Calif., April 8, 200...ounced today that Bristol-Myers,Squibb Company (NY...ies,collaboration as a development candidate. As a...payment. The two companies have an ongoing,collabo...protein convertase,subtilisin kexin 9 (PCSK9). The...
...2008 For a woman facing,gynecologic cancer surger...choose a gynecologic oncologist, a physician who h...eatment of cancers of the female reproductive,syst...lose proximity to,other major organs in the abdome...e reproductive organs can easily spread to the bla...
Other Biology Technology:Amsterdam Molecular Therapeutics Part of Next Biotech Index 2BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 2BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 3BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 4Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot 2
(Date:11/24/2009)...secrets of the earth,s history locked in its icy d...tle information on the environments that have been.... Now, a team of researchers from nine institution...$10 million dollars by the National Science Founda...rally. These scientists will drill through the Wes...
(Date:11/24/2009)... , The presence of increased body fat, and t...in the blood, hinders the loss and maintenance of ... University of Navarra conducted by Estbaliz Goyen... , The project, entitled "A nutrigenetic and nut... weight and inflammation," examines how the indivi...
(Date:11/23/2009)... Applied mathematicians dissected the morphology o...teristic long leaf with a saddle-like arc midsecti... simple cause of the lily,s fan-like shapeelastic ...ial growthwas revealed by using an equally simple ...g, a postdoctoral student at Harvard,s School of E...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 1Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 2Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 3Teens Young Adults Need More Milk 49386 1Teens Young Adults Need More Milk 49386 2Aerobically unfit young adults on road to diabetes in middle age 49381 1Aerobically unfit young adults on road to diabetes in middle age 49381 2
...research has shown that resveratrol, a common diet...tion that leads to most types of breast cancer, su...cancer prevention. ,Resveratrol is a natural subst...in extract form as a dietary supplement at most ma...to prevent the first step that occurs when estroge...
...incident that led to the death of 26 dolphins near...heds new light on the extent of the problems facin...iversity of Exeter and Cornwall Wildlife Trust, pu...ion , has revealed a disturbing rise in the number...ornish beaches. The frequency of these mammals, co...
... patients with aggressive non-Hodgkin,s lymphoma i...ed chemotherapy regimen, researchers say. , At th...uropean Society for Medical Oncology, a group head...ts that giving these patients chemotherapy every 2...ed treatment outcomes. , The standard regimen in ...
Other Biology News:Researchers identify cancer preventive properties in common vitamin supplement 2Study shows rise in Cornwall's dolphin, whale and porpoise deaths 2New treatment approach promising for lymphoma patients in the developing world 2
Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec
Captivate magnetic separator for six microtubes from Molecular Probes (Invitrogen)
Protein Purification Applications from Promega
...ibes the basic equipment required, principles and ... and detection. Methods such as radiometric and bi...included. Other topics covered are, the detection ...chains and the study of DNA binding of immobilized...
Biology Products: